img

Global Sickle Cell Disease Drug Sales Market Report 2024


Published on: 2024-01-04 | No of Pages : 282 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Sickle Cell Disease Drug Sales Market Report 2024

The global Sickle Cell Disease Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sickle Cell Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
ARQ-092
BIVV-003
CAL-H
CTX-001
DRX-194
Others


Segment by Application


Hospital
Clinic
Others

The Sickle Cell Disease Drug market is analysed and market size information is provided by regions (countries).

Segment by Application

, the Sickle Cell Disease Drug market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.




By Company


Acceleron Pharma Inc
Addmedica SAS
Angiocrine Bioscience Inc
Annexin Pharmaceuticals AB
ArQule Inc
Bio Products Laboratory Ltd
Bioverativ Inc
bluebird bio Inc
Bristol-Myers Squibb Co
Calimmune Inc
CRISPR Therapeutics
CSL Ltd
Daiichi Sankyo Co Ltd
Editas Medicine Inc
Errant Gene Therapeutics LLC
Gamida Cell Ltd
Genethon SA
Gilead Sciences Inc
Global Blood Therapeutics Inc

Table of Content

1 Sickle Cell Disease Drug Market Overview
1.1 Sickle Cell Disease Drug Product Scope
1.2 Sickle Cell Disease Drug Segment by Type
1.2.1 Global Sickle Cell Disease Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 ARQ-092
1.2.3 BIVV-003
1.2.4 CAL-H
1.2.5 CTX-001
1.2.6 DRX-194
1.2.7 Others
1.3 Sickle Cell Disease Drug Segment by Application
1.3.1 Global Sickle Cell Disease Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Sickle Cell Disease Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Sickle Cell Disease Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Sickle Cell Disease Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Sickle Cell Disease Drug Price Trends (2016-2027)

2 Sickle Cell Disease Drug Estimates and Forecasts by Region
2.1 Global Sickle Cell Disease Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Sickle Cell Disease Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Sickle Cell Disease Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Sickle Cell Disease Drug Revenue Market Share by Region (2016-2021)
2.3 Global Sickle Cell Disease Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Sickle Cell Disease Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Sickle Cell Disease Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Sickle Cell Disease Drug Estimates and Projections (2016-2027)
2.4.2 Europe Sickle Cell Disease Drug Estimates and Projections (2016-2027)
2.4.3 China Sickle Cell Disease Drug Estimates and Projections (2016-2027)
2.4.4 Japan Sickle Cell Disease Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Sickle Cell Disease Drug Estimates and Projections (2016-2027)
2.4.6 India Sickle Cell Disease Drug Estimates and Projections (2016-2027)

3 Global Sickle Cell Disease Drug Competition Landscape by Players
3.1 Global Top Sickle Cell Disease Drug Players by Sales (2016-2021)
3.2 Global Top Sickle Cell Disease Drug Players by Revenue (2016-2021)
3.3 Global Sickle Cell Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sickle Cell Disease Drug as of 2020)
3.4 Global Sickle Cell Disease Drug Average Price by Company (2016-2021)
3.5 Manufacturers Sickle Cell Disease Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Sickle Cell Disease Drug Market Size by Type
4.1 Global Sickle Cell Disease Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Sickle Cell Disease Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Sickle Cell Disease Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Sickle Cell Disease Drug Price by Type (2016-2021)
4.2 Global Sickle Cell Disease Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Sickle Cell Disease Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Sickle Cell Disease Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Sickle Cell Disease Drug Price Forecast by Type (2022-2027)

5 Global Sickle Cell Disease Drug Market Size by Application
5.1 Global Sickle Cell Disease Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Sickle Cell Disease Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Sickle Cell Disease Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Sickle Cell Disease Drug Price by Application (2016-2021)
5.2 Global Sickle Cell Disease Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Sickle Cell Disease Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Sickle Cell Disease Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Sickle Cell Disease Drug Price Forecast by Application (2022-2027)

6 North America Sickle Cell Disease Drug Market Facts & Figures
6.1 North America Sickle Cell Disease Drug Sales by Company
6.1.1 North America Sickle Cell Disease Drug Sales by Company (2016-2021)
6.1.2 North America Sickle Cell Disease Drug Revenue by Company (2016-2021)
6.2 North America Sickle Cell Disease Drug Sales Breakdown by Type
6.2.1 North America Sickle Cell Disease Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Sickle Cell Disease Drug Sales Breakdown by Type (2022-2027)
6.3 North America Sickle Cell Disease Drug Sales Breakdown by Application
6.3.1 North America Sickle Cell Disease Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Sickle Cell Disease Drug Sales Breakdown by Application (2022-2027)

7 Europe Sickle Cell Disease Drug Market Facts & Figures
7.1 Europe Sickle Cell Disease Drug Sales by Company
7.1.1 Europe Sickle Cell Disease Drug Sales by Company (2016-2021)
7.1.2 Europe Sickle Cell Disease Drug Revenue by Company (2016-2021)
7.2 Europe Sickle Cell Disease Drug Sales Breakdown by Type
7.2.1 Europe Sickle Cell Disease Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Sickle Cell Disease Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Sickle Cell Disease Drug Sales Breakdown by Application
7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)

8 China Sickle Cell Disease Drug Market Facts & Figures
8.1 China Sickle Cell Disease Drug Sales by Company
8.1.1 China Sickle Cell Disease Drug Sales by Company (2016-2021)
8.1.2 China Sickle Cell Disease Drug Revenue by Company (2016-2021)
8.2 China Sickle Cell Disease Drug Sales Breakdown by Type
8.2.1 China Sickle Cell Disease Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Sickle Cell Disease Drug Sales Breakdown by Type (2022-2027)
8.3 China Sickle Cell Disease Drug Sales Breakdown by Application
8.3.1 China 163 Sales Breakdown by Application (2016-2021)
8.3.2 China 163 Sales Breakdown by Application (2022-2027)

9 Japan Sickle Cell Disease Drug Market Facts & Figures
9.1 Japan Sickle Cell Disease Drug Sales by Company
9.1.1 Japan Sickle Cell Disease Drug Sales by Company (2016-2021)
9.1.2 Japan Sickle Cell Disease Drug Revenue by Company (2016-2021)
9.2 Japan Sickle Cell Disease Drug Sales Breakdown by Type
9.2.1 Japan Sickle Cell Disease Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Sickle Cell Disease Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Sickle Cell Disease Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Sickle Cell Disease Drug Market Facts & Figures
10.1 Southeast Asia Sickle Cell Disease Drug Sales by Company
10.1.1 Southeast Asia Sickle Cell Disease Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Sickle Cell Disease Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Sickle Cell Disease Drug Sales Breakdown by Type
10.2.1 Southeast Asia Sickle Cell Disease Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Sickle Cell Disease Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Sickle Cell Disease Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Sickle Cell Disease Drug Market Facts & Figures
11.1 India Sickle Cell Disease Drug Sales by Company
11.1.1 India Sickle Cell Disease Drug Sales by Company (2016-2021)
11.1.2 India Sickle Cell Disease Drug Revenue by Company (2016-2021)
11.2 India Sickle Cell Disease Drug Sales Breakdown by Type
11.2.1 India Sickle Cell Disease Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Sickle Cell Disease Drug Sales Breakdown by Type (2022-2027)
11.3 India Sickle Cell Disease Drug Sales Breakdown by Application
11.3.1 India Sickle Cell Disease Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Sickle Cell Disease Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Sickle Cell Disease Drug Business
12.1 Acceleron Pharma Inc
12.1.1 Acceleron Pharma Inc Corporation Information
12.1.2 Acceleron Pharma Inc Business Overview
12.1.3 Acceleron Pharma Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Acceleron Pharma Inc Sickle Cell Disease Drug Products Offered
12.1.5 Acceleron Pharma Inc Recent Development
12.2 Addmedica SAS
12.2.1 Addmedica SAS Corporation Information
12.2.2 Addmedica SAS Business Overview
12.2.3 Addmedica SAS Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Addmedica SAS Sickle Cell Disease Drug Products Offered
12.2.5 Addmedica SAS Recent Development
12.3 Angiocrine Bioscience Inc
12.3.1 Angiocrine Bioscience Inc Corporation Information
12.3.2 Angiocrine Bioscience Inc Business Overview
12.3.3 Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Angiocrine Bioscience Inc Sickle Cell Disease Drug Products Offered
12.3.5 Angiocrine Bioscience Inc Recent Development
12.4 Annexin Pharmaceuticals AB
12.4.1 Annexin Pharmaceuticals AB Corporation Information
12.4.2 Annexin Pharmaceuticals AB Business Overview
12.4.3 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Products Offered
12.4.5 Annexin Pharmaceuticals AB Recent Development
12.5 ArQule Inc
12.5.1 ArQule Inc Corporation Information
12.5.2 ArQule Inc Business Overview
12.5.3 ArQule Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 ArQule Inc Sickle Cell Disease Drug Products Offered
12.5.5 ArQule Inc Recent Development
12.6 Bio Products Laboratory Ltd
12.6.1 Bio Products Laboratory Ltd Corporation Information
12.6.2 Bio Products Laboratory Ltd Business Overview
12.6.3 Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bio Products Laboratory Ltd Sickle Cell Disease Drug Products Offered
12.6.5 Bio Products Laboratory Ltd Recent Development
12.7 Bioverativ Inc
12.7.1 Bioverativ Inc Corporation Information
12.7.2 Bioverativ Inc Business Overview
12.7.3 Bioverativ Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Bioverativ Inc Sickle Cell Disease Drug Products Offered
12.7.5 Bioverativ Inc Recent Development
12.8 bluebird bio Inc
12.8.1 bluebird bio Inc Corporation Information
12.8.2 bluebird bio Inc Business Overview
12.8.3 bluebird bio Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 bluebird bio Inc Sickle Cell Disease Drug Products Offered
12.8.5 bluebird bio Inc Recent Development
12.9 Bristol-Myers Squibb Co
12.9.1 Bristol-Myers Squibb Co Corporation Information
12.9.2 Bristol-Myers Squibb Co Business Overview
12.9.3 Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Bristol-Myers Squibb Co Sickle Cell Disease Drug Products Offered
12.9.5 Bristol-Myers Squibb Co Recent Development
12.10 Calimmune Inc
12.10.1 Calimmune Inc Corporation Information
12.10.2 Calimmune Inc Business Overview
12.10.3 Calimmune Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Calimmune Inc Sickle Cell Disease Drug Products Offered
12.10.5 Calimmune Inc Recent Development
12.11 CRISPR Therapeutics
12.11.1 CRISPR Therapeutics Corporation Information
12.11.2 CRISPR Therapeutics Business Overview
12.11.3 CRISPR Therapeutics Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 CRISPR Therapeutics Sickle Cell Disease Drug Products Offered
12.11.5 CRISPR Therapeutics Recent Development
12.12 CSL Ltd
12.12.1 CSL Ltd Corporation Information
12.12.2 CSL Ltd Business Overview
12.12.3 CSL Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 CSL Ltd Sickle Cell Disease Drug Products Offered
12.12.5 CSL Ltd Recent Development
12.13 Daiichi Sankyo Co Ltd
12.13.1 Daiichi Sankyo Co Ltd Corporation Information
12.13.2 Daiichi Sankyo Co Ltd Business Overview
12.13.3 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Products Offered
12.13.5 Daiichi Sankyo Co Ltd Recent Development
12.14 Editas Medicine Inc
12.14.1 Editas Medicine Inc Corporation Information
12.14.2 Editas Medicine Inc Business Overview
12.14.3 Editas Medicine Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Editas Medicine Inc Sickle Cell Disease Drug Products Offered
12.14.5 Editas Medicine Inc Recent Development
12.15 Errant Gene Therapeutics LLC
12.15.1 Errant Gene Therapeutics LLC Corporation Information
12.15.2 Errant Gene Therapeutics LLC Business Overview
12.15.3 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Products Offered
12.15.5 Errant Gene Therapeutics LLC Recent Development
12.16 Gamida Cell Ltd
12.16.1 Gamida Cell Ltd Corporation Information
12.16.2 Gamida Cell Ltd Business Overview
12.16.3 Gamida Cell Ltd Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Gamida Cell Ltd Sickle Cell Disease Drug Products Offered
12.16.5 Gamida Cell Ltd Recent Development
12.17 Genethon SA
12.17.1 Genethon SA Corporation Information
12.17.2 Genethon SA Business Overview
12.17.3 Genethon SA Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Genethon SA Sickle Cell Disease Drug Products Offered
12.17.5 Genethon SA Recent Development
12.18 Gilead Sciences Inc
12.18.1 Gilead Sciences Inc Corporation Information
12.18.2 Gilead Sciences Inc Business Overview
12.18.3 Gilead Sciences Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Gilead Sciences Inc Sickle Cell Disease Drug Products Offered
12.18.5 Gilead Sciences Inc Recent Development
12.19 Global Blood Therapeutics Inc
12.19.1 Global Blood Therapeutics Inc Corporation Information
12.19.2 Global Blood Therapeutics Inc Business Overview
12.19.3 Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Global Blood Therapeutics Inc Sickle Cell Disease Drug Products Offered
12.19.5 Global Blood Therapeutics Inc Recent Development

13 Sickle Cell Disease Drug Manufacturing Cost Analysis
13.1 Sickle Cell Disease Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Sickle Cell Disease Drug
13.4 Sickle Cell Disease Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Sickle Cell Disease Drug Distributors List
14.3 Sickle Cell Disease Drug Customers

15 Market Dynamics
15.1 Sickle Cell Disease Drug Market Trends
15.2 Sickle Cell Disease Drug Drivers
15.3 Sickle Cell Disease Drug Market Challenges
15.4 Sickle Cell Disease Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Sickle Cell Disease Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Sickle Cell Disease Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Sickle Cell Disease Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Sickle Cell Disease Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global Sickle Cell Disease Drug Sales Market Share by Region (2016-2021)
Table 6. Global Sickle Cell Disease Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Sickle Cell Disease Drug Revenue Share by Region (2016-2021)
Table 8. Global Sickle Cell Disease Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Sickle Cell Disease Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Sickle Cell Disease Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Sickle Cell Disease Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Sickle Cell Disease Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Sickle Cell Disease Drug Sales Share by Company (2016-2021)
Table 14. Global Sickle Cell Disease Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Sickle Cell Disease Drug Revenue Share by Company (2016-2021)
Table 16. Global Sickle Cell Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell Disease Drug as of 2020)
Table 17. Global Sickle Cell Disease Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Sickle Cell Disease Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Sickle Cell Disease Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Sickle Cell Disease Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global Sickle Cell Disease Drug Sales Share by Type (2016-2021)
Table 23. Global Sickle Cell Disease Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Sickle Cell Disease Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Sickle Cell Disease Drug Sales Share by Type (2022-2027)
Table 26. Global Sickle Cell Disease Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Sickle Cell Disease Drug Revenue Share by Type (2022-2027)
Table 28. Global Sickle Cell Disease Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Sickle Cell Disease Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global Sickle Cell Disease Drug Sales Share by Application (2016-2021)
Table 31. Global Sickle Cell Disease Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Sickle Cell Disease Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Sickle Cell Disease Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global Sickle Cell Disease Drug Sales Share by Application (2022-2027)
Table 35. Global Sickle Cell Disease Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Sickle Cell Disease Drug Revenue Share by Application (2022-2027)
Table 37. Global Sickle Cell Disease Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Sickle Cell Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America Sickle Cell Disease Drug Sales Market Share by Company (2016-2021)
Table 40. North America Sickle Cell Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Sickle Cell Disease Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Sickle Cell Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Sickle Cell Disease Drug Sales Market Share by Type (2016-2021)
Table 44. North America Sickle Cell Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Sickle Cell Disease Drug Sales Market Share by Type (2022-2027)
Table 46. North America Sickle Cell Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Sickle Cell Disease Drug Sales Market Share by Application (2016-2021)
Table 48. North America Sickle Cell Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Sickle Cell Disease Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Sickle Cell Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Sickle Cell Disease Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Sickle Cell Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Sickle Cell Disease Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Sickle Cell Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Sickle Cell Disease Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Sickle Cell Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Sickle Cell Disease Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Sickle Cell Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Sickle Cell Disease Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Sickle Cell Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Sickle Cell Disease Drug Sales Market Share by Application (2022-2027)
Table 62. China Sickle Cell Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China Sickle Cell Disease Drug Sales Market Share by Company (2016-2021)
Table 64. China Sickle Cell Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Sickle Cell Disease Drug Revenue Market Share by Company (2016-2021)
Table 66. China Sickle Cell Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China Sickle Cell Disease Drug Sales Market Share by Type (2016-2021)
Table 68. China Sickle Cell Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China Sickle Cell Disease Drug Sales Market Share by Type (2022-2027)
Table 70. China Sickle Cell Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China Sickle Cell Disease Drug Sales Market Share by Application (2016-2021)
Table 72. China Sickle Cell Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China Sickle Cell Disease Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Sickle Cell Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Sickle Cell Disease Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Sickle Cell Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Sickle Cell Disease Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Sickle Cell Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Sickle Cell Disease Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Sickle Cell Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Sickle Cell Disease Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Sickle Cell Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Sickle Cell Disease Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Sickle Cell Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Sickle Cell Disease Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Sickle Cell Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Sickle Cell Disease Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Sickle Cell Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Sickle Cell Disease Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Sickle Cell Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Sickle Cell Disease Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Sickle Cell Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Sickle Cell Disease Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Sickle Cell Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Sickle Cell Disease Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Sickle Cell Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Sickle Cell Disease Drug Sales Market Share by Application (2022-2027)
Table 98. India Sickle Cell Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India Sickle Cell Disease Drug Sales Market Share by Company (2016-2021)
Table 100. India Sickle Cell Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Sickle Cell Disease Drug Revenue Market Share by Company (2016-2021)
Table 102. India Sickle Cell Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India Sickle Cell Disease Drug Sales Market Share by Type (2016-2021)
Table 104. India Sickle Cell Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India Sickle Cell Disease Drug Sales Market Share by Type (2022-2027)
Table 106. India Sickle Cell Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India Sickle Cell Disease Drug Sales Market Share by Application (2016-2021)
Table 108. India Sickle Cell Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India Sickle Cell Disease Drug Sales Market Share by Application (2022-2027)
Table 110. Acceleron Pharma Inc Corporation Information
Table 111. Acceleron Pharma Inc Description and Business Overview
Table 112. Acceleron Pharma Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Acceleron Pharma Inc Sickle Cell Disease Drug Product
Table 114. Acceleron Pharma Inc Recent Development
Table 115. Addmedica SAS Corporation Information
Table 116. Addmedica SAS Description and Business Overview
Table 117. Addmedica SAS Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Addmedica SAS Sickle Cell Disease Drug Product
Table 119. Addmedica SAS Recent Development
Table 120. Angiocrine Bioscience Inc Corporation Information
Table 121. Angiocrine Bioscience Inc Description and Business Overview
Table 122. Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Angiocrine Bioscience Inc Sickle Cell Disease Drug Product
Table 124. Angiocrine Bioscience Inc Recent Development
Table 125. Annexin Pharmaceuticals AB Corporation Information
Table 126. Annexin Pharmaceuticals AB Description and Business Overview
Table 127. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product
Table 129. Annexin Pharmaceuticals AB Recent Development
Table 130. ArQule Inc Corporation Information
Table 131. ArQule Inc Description and Business Overview
Table 132. ArQule Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. ArQule Inc Sickle Cell Disease Drug Product
Table 134. ArQule Inc Recent Development
Table 135. Bio Products Laboratory Ltd Corporation Information
Table 136. Bio Products Laboratory Ltd Description and Business Overview
Table 137. Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Bio Products Laboratory Ltd Sickle Cell Disease Drug Product
Table 139. Bio Products Laboratory Ltd Recent Development
Table 140. Bioverativ Inc Corporation Information
Table 141. Bioverativ Inc Description and Business Overview
Table 142. Bioverativ Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Bioverativ Inc Sickle Cell Disease Drug Product
Table 144. Bioverativ Inc Recent Development
Table 145. bluebird bio Inc Corporation Information
Table 146. bluebird bio Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. bluebird bio Inc Description and Business Overview
Table 148. bluebird bio Inc Sickle Cell Disease Drug Product
Table 149. bluebird bio Inc Recent Development
Table 150. Bristol-Myers Squibb Co Corporation Information
Table 151. Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Bristol-Myers Squibb Co Description and Business Overview
Table 153. Bristol-Myers Squibb Co Sickle Cell Disease Drug Product
Table 154. Bristol-Myers Squibb Co Recent Development
Table 155. Calimmune Inc Corporation Information
Table 156. Calimmune Inc Description and Business Overview
Table 157. Calimmune Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. Calimmune Inc Sickle Cell Disease Drug Product
Table 159. Calimmune Inc Recent Development
Table 160. CRISPR Therapeutics Corporation Information
Table 161. CRISPR Therapeutics Description and Business Overview
Table 162. CRISPR Therapeutics Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. CRISPR Therapeutics Sickle Cell Disease Drug Product
Table 164. CRISPR Therapeutics Recent Development
Table 165. CSL Ltd Corporation Information
Table 166. CSL Ltd Description and Business Overview
Table 167. CSL Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. CSL Ltd Sickle Cell Disease Drug Product
Table 169. CSL Ltd Recent Development
Table 170. Daiichi Sankyo Co Ltd Corporation Information
Table 171. Daiichi Sankyo Co Ltd Description and Business Overview
Table 172. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product
Table 174. Daiichi Sankyo Co Ltd Recent Development
Table 175. Editas Medicine Inc Corporation Information
Table 176. Editas Medicine Inc Description and Business Overview
Table 177. Editas Medicine Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. Editas Medicine Inc Sickle Cell Disease Drug Product
Table 179. Editas Medicine Inc Recent Development
Table 180. Errant Gene Therapeutics LLC Corporation Information
Table 181. Errant Gene Therapeutics LLC Description and Business Overview
Table 182. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product
Table 184. Errant Gene Therapeutics LLC Recent Development
Table 185. Gamida Cell Ltd Corporation Information
Table 186. Gamida Cell Ltd Description and Business Overview
Table 187. Gamida Cell Ltd Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 188. Gamida Cell Ltd Sickle Cell Disease Drug Product
Table 189. Gamida Cell Ltd Recent Development
Table 190. Genethon SA Corporation Information
Table 191. Genethon SA Description and Business Overview
Table 192. Genethon SA Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 193. Genethon SA Sickle Cell Disease Drug Product
Table 194. Genethon SA Recent Development
Table 195. Gilead Sciences Inc Corporation Information
Table 196. Gilead Sciences Inc Description and Business Overview
Table 197. Gilead Sciences Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 198. Gilead Sciences Inc Sickle Cell Disease Drug Product
Table 199. Gilead Sciences Inc Recent Development
Table 200. Global Blood Therapeutics Inc Corporation Information
Table 201. Global Blood Therapeutics Inc Description and Business Overview
Table 202. Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 203. Global Blood Therapeutics Inc Sickle Cell Disease Drug Product
Table 204. Global Blood Therapeutics Inc Recent Development
Table 205. Production Base and Market Concentration Rate of Raw Material
Table 206. Key Suppliers of Raw Materials
Table 207. Sickle Cell Disease Drug Distributors List
Table 208. Sickle Cell Disease Drug Customers List
Table 209. Sickle Cell Disease Drug Market Trends
Table 210. Sickle Cell Disease Drug Market Drivers
Table 211. Sickle Cell Disease Drug Market Challenges
Table 212. Sickle Cell Disease Drug Market Restraints
Table 213. Research Programs/Design for This Report
Table 214. Key Data Information from Secondary Sources
Table 215. Key Data Information from Primary Sources
List of Figures
Figure 1. Sickle Cell Disease Drug Product Picture
Figure 2. Global Sickle Cell Disease Drug Sales Market Share by Type in 2021 & 2027
Figure 3. ARQ-092 Product Picture
Figure 4. BIVV-003 Product Picture
Figure 5. CAL-H Product Picture
Figure 6. CTX-001 Product Picture
Figure 7. DRX-194 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Sickle Cell Disease Drug Sales Market Share by Application in 2021 & 2027
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Others Examples
Figure 13. Global Sickle Cell Disease Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Sickle Cell Disease Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 15. Global Sickle Cell Disease Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 16. Global Sickle Cell Disease Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 17. Global Sickle Cell Disease Drug Revenue Market Share by Region: 2016 VS 2021
Figure 18. Global Sickle Cell Disease Drug Revenue Market Share by Region: 2021 VS 2027
Figure 19. North America Sickle Cell Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. North America Sickle Cell Disease Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 21. Europe Sickle Cell Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Europe Sickle Cell Disease Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 23. China Sickle Cell Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. China Sickle Cell Disease Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 25. Japan Sickle Cell Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Japan Sickle Cell Disease Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Sickle Cell Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Sickle Cell Disease Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 29. India Sickle Cell Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 30. India Sickle Cell Disease Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 31. Global 5 Largest Sickle Cell Disease Drug Players Market Share by Revenue in Sickle Cell Disease Drug: 2016 & 2020
Figure 32. Sickle Cell Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 33. Global Sickle Cell Disease Drug Revenue Share by Type (2016-2021)
Figure 34. Global Sickle Cell Disease Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 35. Global Sickle Cell Disease Drug Revenue Share by Application (2016-2021)
Figure 36. Global Sickle Cell Disease Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Sickle Cell Disease Drug Sales Market Share by Type in 2020
Figure 38. North America Sickle Cell Disease Drug Sales Market Share by Application in 2020
Figure 39. Europe Sickle Cell Disease Drug Sales Market Share by Type in 2020
Figure 40. Europe Sickle Cell Disease Drug Sales Market Share by Application in 2020
Figure 41. China Sickle Cell Disease Drug Sales Market Share by Type in 2020
Figure 42. China Sickle Cell Disease Drug Sales Market Share by Application in 2020
Figure 43. Japan Sickle Cell Disease Drug Sales Market Share by Type in 2020
Figure 44. Japan Sickle Cell Disease Drug Sales Market Share by Application in 2020
Figure 45. Southeast Asia Sickle Cell Disease Drug Sales Market Share by Type in 2020
Figure 46. Southeast Asia Sickle Cell Disease Drug Sales Market Share by Application in 2020
Figure 47. India Sickle Cell Disease Drug Sales Market Share by Type in 2020
Figure 48. India Sickle Cell Disease Drug Sales Market Share by Application in 2020
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Sickle Cell Disease Drug
Figure 51. Manufacturing Process Analysis of Sickle Cell Disease Drug
Figure 52. Sickle Cell Disease Drug Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed